Erste Asset Management Gmb H Passage Bio, Inc. Transaction History

Erste Asset Management Gmb H

$11.9 Trillion
Q2 2025

A detailed history of Erste Asset Management Gmb H transactions in Passage Bio, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 2,455,800 shares of PASG stock, worth $13.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,455,800

Previous 2,455,800 -0.0%

Holding current value

$13.8 Million

Previous $869 Million 12.72%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.64 - $1.0 $1.57 Million - $2.46 Million	2,455,800 New	2,455,800 $1.72 Billion
Q1 2024 Nov 26, 2024	SELL	$0.86 - $1.73 $434,300 - $873,650	-505,000 Reduced 17.06%	2,455,800 $3.31 Billion
Q4 2023 Nov 26, 2024	BUY	$0.6 - $1.01 $360,000 - $606,000	600,000 Added 25.42%	2,960,800 $2.99 Billion
Q3 2023 Nov 26, 2024	BUY	$0.66 - $1.01 $528,000 - $808,000	800,000 Added 51.26%	2,360,800 $1.55 Billion
Q2 2023 Nov 26, 2024	BUY	$0.82 - $1.19 $491,999 - $714,000	600,000 Added 38.44%	2,160,800 $2.03 Billion
Q1 2023 Nov 26, 2024	BUY	$0.96 - $1.88 $374,400 - $733,200	390,000 Added 33.31%	1,560,800 $1.5 Billion
Q4 2022 Nov 26, 2024	BUY	$1.06 - $1.48 $413,400 - $577,200	390,000 Added 33.31%	1,560,800 $2.15 Billion
Q3 2022 Nov 26, 2024	SELL	$1.22 - $2.48 $1.57 Million - $3.19 Million	-1,285,000 Reduced 52.33%	1,170,800 $1.46 Billion
Q2 2022 Nov 26, 2024	SELL	$1.63 - $3.46 $2.09 Million - $4.45 Million	-1,285,000 Reduced 52.33%	1,170,800 $2.76 Billion
Q1 2022 Nov 22, 2024	SELL	$2.66 - $6.49 $3.82 Million - $9.31 Million	-1,435,000 Reduced 58.43%	1,020,800 $3.16 Billion
Q4 2021 Nov 22, 2024	SELL	$6.24 - $10.2 $12 Million - $19.6 Million	-1,920,800 Reduced 78.21%	535,000 $3.34 Billion

Others Institutions Holding PASG

# of Institutions

Shares Held

35.3M

Call Options Held

40.5K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $306M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Passage Bio, Inc. Transaction History